grapiprant

DRUG2 trials

Sponsors

Arrys Therapeutics, M.D. Anderson Cancer Center

Conditions

Breast Inflammatory CarcinomaMicrosatellite Stable Colorectal CancerRecurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma

Phase 1

Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer

CompletedNCT03658772

Arrys TherapeuticsMicrosatellite Stable Colorectal Cancer

Start: 2018-09-20End: 2023-03-07Updated: 2023-10-24

Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer

TerminatedNCT05041101

M.D. Anderson Cancer CenterBreast Inflammatory Carcinoma, Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma

Start: 2021-12-21End: 2024-09-06Updated: 2025-06-13